Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Expression of recombinant human quick skeletal muscle type troponin C in colibacillus and its application for resisting tumor

A technology of troponin and recombinant plasmids, which is applied in the direction of anti-tumor drugs, applications, peptide/protein components, etc., and can solve the problems of difficulty in direct separation and purification, and failure to meet needs

Inactive Publication Date: 2003-04-23
重庆康尔威药业股份有限公司
View PDF0 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

It is obviously quite difficult to directly separate and purify, and it cannot meet the needs of clinical treatment drugs.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Expression of recombinant human quick skeletal muscle type troponin C in colibacillus and its application for resisting tumor
  • Expression of recombinant human quick skeletal muscle type troponin C in colibacillus and its application for resisting tumor
  • Expression of recombinant human quick skeletal muscle type troponin C in colibacillus and its application for resisting tumor

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0020] The present invention will be further described below by way of examples. Example 1: Cloning and expression of the gene encoding human troponin TnC Primer design and synthesis

[0021] According to the known cDNA sequence of human troponin TnC, two primers were designed and synthesized, the sequences of which are as follows: 5'-end primer: 5'-AAC AGA GGA GGA GTC CCG GTC ACC AGC-3'3'-end primer: 5'-CTC CTT ACT GCA CGC CCT CCA TCA T-3′PCR

[0022] Using the human breast cDNA library as a template, a human troponin C (TnC) cDNA fragment with a length of 540 base pairs was amplified by PCR using the above two primers. The PCR reaction conditions are: 1 microgram of human breast cDNA library, 0.5 micrograms of each of the above two primers, 2 microliters of 10mM dNTPs, 10 microliters of 10×PCR buffer, 2.5 units of Taq DNA polymerase, and water to a final volume of 100 microliters. The PCR reaction was carried out in the PCR instrument according to the following temperature...

Embodiment 2

[0029] The pET3b-TnC expression plasmid was transformed into Escherichia coli BL21(DE3)pLysS, and the transformants with resistance to ampicillin and chloramphenicol were screened. The expression products were analyzed by SDS-PAGE ( image 3 ) analysis, it reached more than 30% of E. coli stainable protein, and the expression product was almost all in the form of soluble protein ( Figure 4 ). The engineered bacterium was named E.coli BL21(DE3)pLysS / pET3b-TnC, and the strain has been preserved in the China Type Culture Collection Center of Wuhan University with the number CCTCC No.M202028. Example 2: Expression and Purification of Human Troponin C Bacterial Culture and IPTG Induction

[0030] Inoculate a single fresh Escherichia coli engineered bacterium (E.coli BL21(DE3)pLysS / pET3b-TnC) into LB medium containing 200 μg / ml ampicillin and 34 μg / ml chloramphenicol, shake at 37°C, and culture overnight. The next day, it was diluted 1:100, and an appropriate amount of overnight...

Embodiment 3

[0033] Equilibrate the column with PBS, load the above product peak solution, elute with PBS, collect in separate tubes, detect by SDS-PAGE, and finally combine and collect the product peaks. see results Image 6 , the grayscale scan of the SDS-DAGE spectrum of the purified protein showed a purity greater than 95%. Embodiment 3: biological activity detection: in vitro activity detection

[0034] Inhibitory effect of recombinant human troponin TnC on the growth of human umbilical vein endothelial cells in vitro. Human umbilical vein endothelial cells (HUV-EC, purchased from Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences) were mixed with 2×10 3 The density of the cell / well is placed on a 96-well plate for culture, and the culture medium is DMEM medium (containing growth factor bFGF 3ng / ml) containing 15% fetal bovine serum, cultured in a 5% CO2 incubator for 24 hours to allow it to adhere to the wall, and then add medicine. After adding diff...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention relates to a method for expression and purification of human troponin C(TnC) and its application using said protein as medicine for resisting angiogenesis. It adopts PCR method,and includes the following steps: obtaining coded sequence of human troponin C from human mammary gland cDNA library; constructing colibacillus expression plasmid containing said coded sequence, pET36-TnC and its transformed colibacillus engineering bacterium strain E. coli BL21(DE3)pLyS / pET36-TnC; and utilizing said engineering bacterium expression to produce human troponin C with biological activity white can inhibit vascular endothelial proliferation and inhibit tumor growth. It can be used as medicine for curing tumor.

Description

Technical field: [0001] The invention relates to a method for expressing and purifying recombinant human fast skeletal muscle troponin C (abbreviation: human troponin C) English abbreviation (TnC) and using the protein as an anti-angiogenesis drug. Background technique: [0002] Human troponin (Troponin, Tn) is a protein involved in the regulation of muscle contraction, with a molecular weight of 76kD. It consists of three subunits, troponin T (TnT, MW37kD), troponin I (TnI, MW21kD) and troponin C (TnC, MW18kD). The role of troponin in muscle contraction has been very clear: TnT contains the binding site of tropomyosin, TnI is the inhibitor of actin ATPase, inhibits the interaction between actin and myosin, TnC and Ca 2+ Binding, modulating the interaction between TnT, TnI and other components of the contractile system. In addition, it was also found that in other non-muscle tissues (including cartilage), there are various proteins involved in the process of muscle contrac...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K38/00A61P35/00C12N1/21C12N15/12C12N15/70C12P21/00
Inventor 周益群刘先俊
Owner 重庆康尔威药业股份有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com